TP53 Gene Mutations in Tumor Cells of Patients with Aggressive B-Cell Lymphomas
Background. TP53 gene mutations impede cell apoptosis and lead to additional oncogenic events contributing to tumor progression. Aim. To assess TP53 gene mutation rate in patients with high-grade B-cell lymphoma double-hit (HGBCL DH) and not otherwise specified (HGBL NOS); to analyse its relationsh...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Practical Medicine Publishing House
2019-05-01
|
Series: | Kliničeskaâ onkogematologiâ |
Subjects: | |
Online Access: |
http://bloodjournal.ru/wp-content/uploads/2019/06/3.pdf
|